- Home
- AGAE vs PMN Comparison
AGAE vs PMN Comparison
Compare AGAE & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGAE
- PMN
- Stock Information
- Founded
- AGAE 2017
- PMN 2004
- Country
- AGAE United States
- PMN Canada
- Employees
- AGAE N/A
- PMN N/A
- Industry
- AGAE Cable & Other Pay Television Services
- PMN Pharmaceuticals and Biotechnology
- Sector
- AGAE Telecommunications
- PMN Health Care
- Exchange
- AGAE Nasdaq
- PMN Nasdaq
- Market Cap
- AGAE 115.6M
- PMN 16.0M
- IPO Year
- AGAE N/A
- PMN N/A
- Fundamental
- Price
- AGAE $1.63
- PMN $0.40
- Analyst Decision
- AGAE
- PMN Strong Buy
- Analyst Count
- AGAE 0
- PMN 2
- Target Price
- AGAE N/A
- PMN $4.50
- AVG Volume (30 Days)
- AGAE 126.0K
- PMN 63.7K
- Earning Date
- AGAE 07-07-2025
- PMN 08-07-2025
- Dividend Yield
- AGAE N/A
- PMN N/A
- EPS Growth
- AGAE N/A
- PMN N/A
- EPS
- AGAE N/A
- PMN N/A
- Revenue
- AGAE $8,975,246.00
- PMN N/A
- Revenue This Year
- AGAE N/A
- PMN N/A
- Revenue Next Year
- AGAE N/A
- PMN N/A
- P/E Ratio
- AGAE N/A
- PMN N/A
- Revenue Growth
- AGAE 1.52
- PMN N/A
- 52 Week Low
- AGAE $0.70
- PMN $0.38
- 52 Week High
- AGAE $3.79
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- AGAE 36.59
- PMN 32.23
- Support Level
- AGAE $1.67
- PMN $0.48
- Resistance Level
- AGAE $1.80
- PMN $0.50
- Average True Range (ATR)
- AGAE 0.28
- PMN 0.03
- MACD
- AGAE -0.16
- PMN -0.01
- Stochastic Oscillator
- AGAE 0.59
- PMN 18.75
About AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.